The future of biologic coatings for orthopaedic implants

Biomaterials

Volumn 34, Issue 13, 2013, Pages 3174-3183

  Goodman, Stuart B ^a,b   Yao, Zhenyu ^a,c   Keeney, Michael ^a,b,c   Yang, Fan ^a,b,c  

^a STANFORD UNIVERSITY   (United States)

^b Stanford University   (United States)

^c NONE   (United States)

Author keywords

Calcium phosphate coatings; Foreign body reaction; Implant coatings; Infection; Orthopaedics; Osseointegration

Indexed keywords

ARTHROPLASTY; CALCIUM PHOSPHATE; ORTHOPEDICS; TISSUE; TISSUE REGENERATION;

BIOLOGICAL ENVIRONMENTS; FOREIGN BODY REACTIONS; INFECTION; ORTHOPAEDIC APPLICATIONS; OSSEOINTEGRATION; PRE-CLINICAL TESTING; SOFT TISSUE ANCHORAGE; TOTAL JOINT ARTHROPLASTY;

PHOSPHATE COATINGS;

AMOXICILLIN; ANTIBIOTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; BONE CEMENT; CALCIUM PHOSPHATE; CARBENICILLIN; CEFALOTIN; CEFAMANDOLE; CHLORHEXIDINE; CHLOROXYLENOL; GENTAMICIN; HYDROXYAPATITE; INTERLEUKIN 12; MONOCYTE CHEMOTACTIC PROTEIN 1; PAMIDRONIC ACID; POLY(HEXAMETHYLENEBIGUANIDE); POLY(METHYL METHACRYLATE); SILVER; TITANIUM; TITANIUM DIOXIDE; TOBRAMYCIN; VANCOMYCIN; ZOLEDRONIC ACID;

ARTICLE; BONE REGENERATION; EQUIPMENT DESIGN; FOREIGN BODY REACTION; FRACTURE HEALING; HUMAN; HYDROGEL; MATERIAL COATING; NONHUMAN; ORTHOPEDIC IMPLANT; ORTHOPEDIC SURGERY; OSTEOCLAST; PRIORITY JOURNAL; PROGNOSIS; PROSTHESIS INFECTION; SURFACE PROPERTY; TREATMENT OUTCOME;

EID: 84874254474     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.01.074     Document Type: Article

References (119)

1. Carter D.R., Beaupre G.S., Giori N.J., Helms J.A. Mechanobiology of skeletal regeneration. Clin Orthop Relat Res 1998, 335:S41-S55.
2. Liu X., Niebur G.L. Bone ingrowth into a porous coated implant predicted by a mechano-regulatory tissue differentiation algorithm. Biomech Model Mechanobiol 2008, 7:335-344.
3. Kienapfel H., Sprey C., Wilke A., Griss P. Implant fixation by bone ingrowth. J Arthroplasty 1999, 14:355-368.
4. Steinmann J.C., Herkowitz H.N. Pseudarthrosis of the spine. Clin Orthop Relat Res 1992, 284:80-90.
5. Bishop J.A., Palanca A.A., Bellino M.J., Lowenberg D.W. Assessment of compromised fracture healing. J Am Acad Orthop Surg 2012, 20:273-282.
6. Aro H.T., Alm J.J., Moritz N., Makinen T.J., Lankinen P. Low BMD affects initial stability and delays stem osseointegration in cementless total hip arthroplasty in women: a 2-year RSA study of 39 patients. Acta Orthop 2012, 83:107-114.
7. Moriarty T.F., Schlegel U., Perren S., Richards R.G. Infection in fracture fixation: can we influence infection rates through implant design?. J Mater Sci Mater Med 2010, 21:1031-1035.
8. Darouiche R.O. Treatment of infections associated with surgical implants. N Engl J Med 2004, 350:1422-1429.
9. Namba R.S., Inacio M.C., Paxton E.W. Risk factors associated with surgical site infection in 30,491 primary total hip replacements. J Bone Jt Surg Br 2012, 94:1330-1338.
10. Hickok N.J., Shapiro I.M. Immobilized antibiotics to prevent orthopaedic implant infections. Adv Drug Deliv Rev 2012, 64:1165-1176.
11. Della Valle C., Parvizi J., Bauer T.W., Dicesare P.E., Evans R.P., Segreti J., et al. Diagnosis of periprosthetic joint infections of the hip and knee. J Am Acad Orthop Surg 2010, 18:760-770.
12. Jamsen E., Furnes O., Engesaeter L.B., Konttinen Y.T., Odgaard A., Stefansdottir A., et al. Prevention of deep infection in joint replacement surgery. Acta Orthop 2010, 81:660-666.
13. van de Belt H., Neut D., Schenk W., van Horn J.R., van der Mei H.C., Busscher H.J. Infection of orthopedic implants and the use of antibiotic-loaded bone cements. A review. Acta Orthop Scand 2001, 72:557-571.
14. Zhao L., Chu P.K., Zhang Y., Wu Z. Antibacterial coatings on titanium implants. J Biomed Mater Res B Appl Biomater 2009, 91:470-480.
15. de Groot K., Geesink R., Klein C.P., Serekian P. Plasma sprayed coatings of hydroxylapatite. J Biomed Mater Res 1987, 21:1375-1381.
16. Geesink R.G., de Groot K., Klein C.P. Chemical implant fixation using hydroxyl-apatite coatings. The development of a human total hip prosthesis for chemical fixation to bone using hydroxyl-apatite coatings on titanium substrates. Clin Orthop Relat Res 1987, 147-170.
17. Geesink R.G., de Groot K., Klein C.P. Bonding of bone to apatite-coated implants. J Bone Jt Surg Br 1988, 70:17-22.
18. He J., Huang T., Gan L., Zhou Z., Jiang B., Wu Y., et al. Collagen-infiltrated porous hydroxyapatite coating and its osteogenic properties: in vitro and in vivo study. J Biomed Mater Res A 2012, 100:1706-1715.
19. LeGeros R.Z. Properties of osteoconductive biomaterials: calcium phosphates. Clin Orthop Relat Res 2002, 395:81-98.
20. Soballe K. Hydroxyapatite ceramic coating for bone implant fixation. Mechanical and histological studies in dogs. Acta Orthop Scand Suppl 1993, 255:1-58.
21. Soballe K., Hansen E.S., Brockstedt-Rasmussen H., Bunger C. Hydroxyapatite coating converts fibrous tissue to bone around loaded implants. J Bone Jt Surg Br 1993, 75:270-278.
22. Jarcho M. Calcium phosphate ceramics as hard tissue prosthetics. Clin Orthop Relat Res 1981, 157:259-278.
23. Sun L., Berndt C.C., Khor K.A., Cheang H.N., Gross K.A. Surface characteristics and dissolution behavior of plasma-sprayed hydroxyapatite coating. J Biomed Mater Res 2002, 62:228-236.
24. Soballe K., Overgaard S., Hansen E.S., Brokstedt-Rasmussen H., Lind M., Bunger C. A review of ceramic coatings for implant fixation. J Long Term Eff Med Implants 1999, 9:131-151.
25. Overgaard S., Bromose U., Lind M., Bunger C., Soballe K. The influence of crystallinity of the hydroxyapatite coating on the fixation of implants. Mechanical and histomorphometric results. J Bone Jt Surg Br 1999, 81:725-731.
26. Rahbek O., Overgaard S., Lind M., Bendix K., Bunger C., Soballe K. Sealing effect of hydroxyapatite coating on peri-implant migration of particles. An experimental study in dogs. J Bone Jt Surg Br 2001, 83:441-447.
27. Geesink R.G. Osteoconductive coatings for total joint arthroplasty. Clin Orthop Relat Res 2002, 395:53-65.
28. Reikeras O., Gunderson R.B. Excellent results of HA coating on a grit-blasted stem: 245 patients followed for 8-12 years. Acta Orthop Scand 2003, 74:140-145.
29. Chambers B., St Clair S.F., Froimson M.I. Hydroxyapatite-coated tapered cementless femoral components in total hip arthroplasty. J Arthroplasty 2007, 22:71-74.
30. Lee J.M., Lee C.W. Comparison of hydroxyapatite-coated and non-hydroxyapatite-coated noncemented total hip arthroplasty in same patients. J Arthroplasty 2007, 22:1019-1023.
31. Lombardi A.V., Berend K.R., Mallory T.H. Hydroxyapatite-coated titanium porous plasma spray tapered stem: experience at 15 to 18 years. Clin Orthop Relat Res 2006, 453:81-85.
32. Goosen J.H., Kums A.J., Kollen B.J., Verheyen C.C. Porous-coated femoral components with or without hydroxyapatite in primary uncemented total hip arthroplasty: a systematic review of randomized controlled trials. Arch Orthop Trauma Surg 2009, 129:1165-1169.
33. Bauer T.W. Hydroxyapatite: coating controversies. Orthopedics 1995, 18:885-888.
34. Bloebaum R.D., Beeks D., Dorr L.D., Savory C.G., DuPont J.A., Hofmann A.A. Complications with hydroxyapatite particulate separation in total hip arthroplasty. Clin Orthop Relat Res 1994, 298:19-26.
35. Morscher E.W., Hefti A., Aebi U. Severe osteolysis after third-body wear due to hydroxyapatite particles from acetabular cup coating. J Bone Jt Surg Br 1998, 80:267-272.
36. Stilling M., Rahbek O., Soballe K. Inferior survival of hydroxyapatite versus titanium-coated cups at 15 years. Clin Orthop Relat Res 2009, 467:2872-2879.
37. Choi S., Murphy W.L. Sustained plasmid DNA release from dissolving mineral coatings. Acta Biomater 2010, 6:3426-3435.
38. Saran N., Zhang R., Turcotte R.E. Osteogenic protein-1 delivered by hydroxyapatite-coated implants improves bone ingrowth in extracortical bone bridging. Clin Orthop Relat Res 2011, 469:1470-1478.
39. Shah N.J., Hong J., Hyder M.N., Hammond P.T. Osteophilic multilayer coatings for accelerated bone tissue growth. Adv Mater 2012, 24:1445-1450.
40. Mathews S., Bhonde R., Gupta P.K., Totey S. A novel tripolymer coating demonstrating the synergistic effect of chitosan, collagen type 1 and hyaluronic acid on osteogenic differentiation of human bone marrow derived mesenchymal stem cells. Biochem Biophys Res Commun 2011, 414:270-276.
41. Rammelt S., Illert T., Bierbaum S., Scharnweber D., Zwipp H., Schneiders W. Coating of titanium implants with collagen, RGD peptide and chondroitin sulfate. Biomaterials 2006, 27:5561-5571.
42. Macdonald M.L., Samuel R.E., Shah N.J., Padera R.F., Beben Y.M., Hammond P.T. Tissue integration of growth factor-eluting layer-by-layer polyelectrolyte multilayer coated implants. Biomaterials 2011, 32:1446-1453.
43. Crouzier T., Ren K., Nicolas C., Roy C., Picart C. Layer-by-layer films as a biomimetic reservoir for rhBMP-2 delivery: controlled differentiation of myoblasts to osteoblasts. Small 2009, 5:598-608.
44. Liu Y., de Groot K., Hunziker E.B. BMP-2 liberated from biomimetic implant coatings induces and sustains direct ossification in an ectopic rat model. Bone 2005, 36:745-757.
45. Auernheimer J., Zukowski D., Dahmen C., Kantlehner M., Enderle A., Goodman S.L., et al. Titanium implant materials with improved biocompatibility through coating with phosphonate-anchored cyclic RGD peptides. Chembiochem 2005, 6:2034-2040.
46. Elmengaard B., Bechtold J.E., Soballe K. In vivo study of the effect of RGD treatment on bone ongrowth on press-fit titanium alloy implants. Biomaterials 2005, 26:3521-3526.
47. Wojtowicz A.M., Shekaran A., Oest M.E., Dupont K.M., Templeman K.L., Hutmacher D.W., et al. Coating of biomaterial scaffolds with the collagen-mimetic peptide GFOGER for bone defect repair. Biomaterials 2010, 31:2574-2582.
48. Dupont K.M., Boerckel J.D., Stevens H.Y., Diab T., Kolambkar Y.M., Takahata M., et al. Synthetic scaffold coating with adeno-associated virus encoding BMP2 to promote endogenous bone repair. Cell Tissue Res 2012, 347:575-588.
49. Ito H., Koefoed M., Tiyapatanaputi P., Gromov K., Goater J.J., Carmouche J., et al. Remodeling of cortical bone allografts mediated by adherent rAAV-RANKL and VEGF gene therapy. Nat Med 2005, 11:291-297.
50. Stadlinger B., Pilling E., Mai R., Bierbaum S., Berhardt R., Scharnweber D., et al. Effect of biological implant surface coatings on bone formation, applying collagen, proteoglycans, glycosaminoglycans and growth factors. J Mater Sci Mater Med 2008, 19:1043-1049.
51. Jayasuriya A.C., Shah C. Controlled release of insulin-like growth factor-1 and bone marrow stromal cell function of bone-like mineral layer-coated poly(lactic-co-glycolic acid) scaffolds. J Tissue Eng Regen Med 2008, 2:43-49.
52. Yoon J.J., Chung H.J., Lee H.J., Park T.G. Heparin-immobilized biodegradable scaffolds for local and sustained release of angiogenic growth factor. J Biomed Mater Res A 2006, 79:934-942.
53. Shah N.J., Macdonald M.L., Beben Y.M., Padera R.F., Samuel R.E., Hammond P.T. Tunable dual growth factor delivery from polyelectrolyte multilayer films. Biomaterials 2011, 32:6183-6193.
54. Petrie T.A., Raynor J.E., Dumbauld D.W., Lee T.T., Jagtap S., Templeman K.L., et al. Multivalent integrin-specific ligands enhance tissue healing and biomaterial integration. Sci Transl Med 2010, 2:45ra60.
55. Zhang J., Montanez S.I., Jewell C.M., Lynn D.M. Multilayered films fabricated from plasmid DNA and a side-chain functionalized poly(beta-amino ester): surface-type erosion and sequential release of multiple plasmid constructs from surfaces. Langmuir: ACS J Surf Colloids 2007, 23:11139-11146.
56. Anderson J.M., Rodriguez A., Chang D.T. Foreign body reaction to biomaterials. Semin Immunol 2008, 20:86-100.
57. Hallab N.J., Jacobs J.J. Biologic effects of implant debris. Bull NYU Hosp Jt Dis 2009, 67:182-188.
58. De Luca G., Dirksen M.T., Spaulding C., Kelbaek H., Schalij M., Thuesen L., et al. Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials. Arch Intern Med 2012, 172:611-621.
59. Wallace E.L., Abdel-Latif A., Charnigo R., Moliterno D.J., Brodie B., Matnani R., et al. Meta-analysis of long-term outcomes for drug-eluting stents versus bare-metal stents in primary percutaneous coronary interventions for ST-segment elevation myocardial infarction. Am J Cardiol 2012, 109:932-940.
60. Gallo J., Goodman S.B., Konttinen Y.T., Raska M. Particle disease: biologic mechanisms of periprosthetic osteolysis in total hip arthroplasty. Innate Immun 2012, PMID: 22751380.
61. Ren P.G., Irani A., Huang Z., Ma T., Biswal S., Goodman S.B. Continuous infusion of UHMWPE particles induces increased bone macrophages and osteolysis. Clin Orthop Relat Res 2011, 469:113-122.
62. Gibon E., Ma T., Ren P.G., Fritton K., Biswal S., Yao Z., et al. Selective inhibition of the MCP-1-CCR2 ligand-receptor axis decreases systemic trafficking of macrophages in the presence of UHMWPE particles. J Orthop Res 2012, 30:547-553.
63. Fritton K., Ren P.G., Gibon E., Rao A.J., Ma T., Biswal S., et al. Exogenous MC3T3 preosteoblasts migrate systemically and mitigate the adverse effects of wear particles. Tissue Eng Part A 2012, 18(23-24):2559-2567.
64. Lin J.H. Bisphosphonates: a review of their pharmacokinetic properties. Bone 1996, 18:75-85.
65. Tanzer M., Karabasz D., Krygier J.J., Cohen R., Bobyn J.D. The Otto Aufranc Award: bone augmentation around and within porous implants by local bisphosphonate elution. Clin Orthop Relat Res 2005, 441:30-39.
66. Bobyn J.D., Hacking S.A., Krygier J.J., Harvey E.J., Little D.G., Tanzer M. Zoledronic acid causes enhancement of bone growth into porous implants. J Bone Jt Surg Br 2005, 87:416-420.
67. Peter B., Pioletti D.P., Laib S., Bujoli B., Pilet P., Janvier P., et al. Calcium phosphate drug delivery system: influence of local zoledronate release on bone implant osteointegration. Bone 2005, 36:52-60.
68. Tengvall P., Skoglund B., Askendal A., Aspenberg P. Surface immobilized bisphosphonate improves stainless-steel screw fixation in rats. Biomaterials 2004, 25:2133-2138.
69. Agholme F., Andersson T., Tengvall P., Aspenberg P. Local bisphosphonate release versus hydroxyapatite coating for stainless steel screw fixation in rat tibiae. J Mater Sci Mater Med 2012, 23:743-752.
70. Niu S., Cao X., Zhang Y., Zhu Q., Zhu J., Zhen P. Peri-implant and systemic effects of high-/low-affinity bisphosphonate-hydroxyapatite composite coatings in a rabbit model with peri-implant high bone turnover. BMC Musculoskelet Disord 2012, 13:97.
71. Gristina A.G. Biomaterial-centered infection: microbial adhesion versus tissue integration. Science 1987, 237:1588-1595.
72. Hetrick E.M., Schoenfisch M.H. Reducing implant-related infections: active release strategies. Chem Soc Rev 2006, 35:780-789.
73. Harris L.G., Richards R.G. Staphylococci and implant surfaces: a review. Injury 2006, 37(Suppl. 2):S3-S14.
74. Dunne W.M. Bacterial adhesion: seen any good biofilms lately?. Clin Microbiol Rev 2002, 15:155-166.
75. Danon D., Kowatch M.A., Roth G.S. Promotion of wound repair in old mice by local injection of macrophages. Proc Natl Acad Sci USA 1989, 86:2018-2020.
76. Costerton J.W., Cheng K.J., Geesey G.G., Ladd T.I., Nickel J.C., Dasgupta M., et al. Bacterial biofilms in nature and disease. Annu Rev Microbiol 1987, 41:435-464.
77. Johansson S., Svineng G., Wennerberg K., Armulik A., Lohikangas L. Fibronectin-integrin interactions. Front Biosci 1997, 2:d126-d146.
78. Fowler T., Wann E.R., Joh D., Johansson S., Foster T.J., Hook M. Cellular invasion by Staphylococcus aureus involves a fibronectin bridge between the bacterial fibronectin-binding MSCRAMMs and host cell beta1 integrins. Eur J Cell Biol 2000, 79:672-679.
79. Gallardo-Moreno A.M., Pacha-Olivenza M.A., Saldana L., Perez-Giraldo C., Bruque J.M., Vilaboa N., et al. In vitro biocompatibility and bacterial adhesion of physico-chemically modified Ti6Al4V surface by means of UV irradiation. Acta Biomater 2009, 5:181-192.
80. Yu J.C., Ho W., Lin J., Yip H., Wong P.K. Photocatalytic activity, antibacterial effect, and photoinduced hydrophilicity of TiO2 films coated on a stainless steel substrate. Environ Sci Technol 2003, 37:2296-2301.
81. Del Curto B., Brunella M.F., Giordano C., Pedeferri M.P., Valtulina V., Visai L., et al. Decreased bacterial adhesion to surface-treated titanium. Int J Artif Organs 2005, 28:718-730.
82. Zhang F., Zhang Z., Zhu X., Kang E.T., Neoh K.G. Silk-functionalized titanium surfaces for enhancing osteoblast functions and reducing bacterial adhesion. Biomaterials 2008, 29:4751-4759.
83. Harris L.G., Tosatti S., Wieland M., Textor M., Richards R.G. Staphylococcus aureus adhesion to titanium oxide surfaces coated with non-functionalized and peptide-functionalized poly(L-lysine)-grafted-poly(ethylene glycol) copolymers. Biomaterials 2004, 25:4135-4148.
84. Kaper H.J., Busscher H.J., Norde W. Characterization of poly(ethylene oxide) brushes on glass surfaces and adhesion of Staphylococcus epidermidis. J Biomat Sci Polym Ed 2003, 14:313-324.
85. Kingshott P., Wei J., Bagge-Ravn D., Gadegaard N., Gram L. Covalent attachment of poly(ethylene glycol) to surfaces, critical for reducing bacterial adhesion. Langmuir 2003, 19:6912-6921.
86. Rivardo F., Turner R.J., Allegrone G., Ceri H., Martinotti M.G. Anti-adhesion activity of two biosurfactants produced by Bacillus spp. prevents biofilm formation of human bacterial pathogens. Appl Microbiol Biotechnol 2009, 83:541-553.
87. Rodrigues L., Banat I.M., Teixeira J., Oliveira R. Biosurfactants: potential applications in medicine. J Antimicrob Chemother 2006, 57:609-618.
88. Buchholz H.W., Engelbrecht H. Depot effects of various antibiotics mixed with Palacos resins. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen 1970, 41:511-515.
89. De Grood M.P. Pathology, diagnosis and treatment of subdural empyema. Arch Chir Neerl 1951, 3:128-138.
90. Buttaro M.A., Pusso R., Piccaluga F. Vancomycin-supplemented impacted bone allografts in infected hip arthroplasty. Two-stage revision results. J Bone Jt Surg Br 2005, 87:314-319.
91. Engesaeter L.B., Lie S.A., Espehaug B., Furnes O., Vollset S.E., Havelin L.I. Antibiotic prophylaxis in total hip arthroplasty: effects of antibiotic prophylaxis systemically and in bone cement on the revision rate of 22,170 primary hip replacements followed 0-14 years in the Norwegian Arthroplasty Register. Acta Orthop Scand 2003, 74:644-651.
92. Alt V., Bitschnau A., Osterling J., Sewing A., Meyer C., Kraus R., et al. The effects of combined gentamicin-hydroxyapatite coating for cementless joint prostheses on the reduction of infection rates in a rabbit infection prophylaxis model. Biomaterials 2006, 27:4627-4634.
93. Stigter M., Bezemer J., de Groot K., Layrolle P. Incorporation of different antibiotics into carbonated hydroxyapatite coatings on titanium implants, release and antibiotic efficacy. J Control Release 2004, 99:127-137.
94. Radin S., Campbell J.T., Ducheyne P., Cuckler J.M. Calcium phosphate ceramic coatings as carriers of vancomycin. Biomaterials 1997, 18:777-782.
95. Gautier H., Daculsi G., Merle C. Association of vancomycin and calcium phosphate by dynamic compaction: in vitro characterization and microbiological activity. Biomaterials 2001, 22:2481-2487.
96. Gautier H., Merle C., Auget J.L., Daculsi G. Isostatic compression, a new process for incorporating vancomycin into biphasic calcium phosphate: comparison with a classical method. Biomaterials 2000, 21:243-249.
97. Yamamura K., Iwata H., Yotsuyanagi T. Synthesis of antibiotic-loaded hydroxyapatite beads and in vitro drug release testing. J Biomed Mater Res 1992, 26:1053-1064.
98. Guillaume O., Garric X., Lavigne J.P., Van Den Berghe H., Coudane J. Multilayer, degradable coating as a carrier for the sustained release of antibiotics: preparation and antimicrobial efficacy in vitro. J Control Release 2012, 162:492-501.
99. Tang Y., Zhao Y., Wang H., Gao Y., Liu X., Wang X., et al. Layer-by-layer assembly of antibacterial coating on interbonded 3D fibrous scaffolds and its cytocompatibility assessment. J Biomed Mater Res A 2012, 100:2071-2078.
100. Radin S., Ducheyne P. Controlled release of vancomycin from thin sol-gel films on titanium alloy fracture plate material. Biomaterials 2007, 28:1721-1729.
101. Antoci V., Adams C.S., Hickok N.J., Shapiro I.M., Parvizi J. Antibiotics for local delivery systems cause skeletal cell toxicity in vitro. Clin Orthop Relat Res 2007, 462:200-206.
102. Ewald A., Gluckermann S.K., Thull R., Gbureck U. Antimicrobial titanium/silver PVD coatings on titanium. Biomed Eng Online 2006, 5:22.
103. Zhang W., Luo Y., Wang H., Jiang J., Pu S., Chu P.K. Ag and Ag/N2 plasma modification of polyethylene for the enhancement of antibacterial properties and cell growth/proliferation. Acta Biomater 2008, 4:2028-2036.
104. Chen W., Liu Y., Courtney H.S., Bettenga M., Agrawal C.M., Bumgardner J.D., et al. In vitro anti-bacterial and biological properties of magnetron co-sputtered silver-containing hydroxyapatite coating. Biomaterials 2006, 27:5512-5517.
105. Secinti K.D., Ayten M., Kahilogullari G., Kaygusuz G., Ugur H.C., Attar A. Antibacterial effects of electrically activated vertebral implants. J Clin Neurosci 2008, 15:434-439.
106. Spadaro J.A., Berger T.J., Barranco S.D., Chapin S.E., Becker R.O. Antibacterial effects of silver electrodes with weak direct current. Antimicrob Agents Chemother 1974, 6:637-642.
107. Campbell A.A., Song L., Li X.S., Nelson B.J., Bottoni C., Brooks D.E., et al. Development, characterization, and anti-microbial efficacy of hydroxyapatite-chlorhexidine coatings produced by surface-induced mineralization. J Biomed Mater Res 2000, 53:400-407.
108. Kozlovsky A., Artzi Z., Moses O., Kamin-Belsky N., Greenstein R.B. Interaction of chlorhexidine with smooth and rough types of titanium surfaces. J Periodontol 2006, 77:1194-1200.
109. Singla A.K., Chawla M. Chitosan: some pharmaceutical and biological aspects-an update. J Pharm Pharmacol 2001, 53:1047-1067.
110. Chua P.H., Neoh K.G., Kang E.T., Wang W. Surface functionalization of titanium with hyaluronic acid/chitosan polyelectrolyte multilayers and RGD for promoting osteoblast functions and inhibiting bacterial adhesion. Biomaterials 2008, 29:1412-1421.
111. Bumgardner J.D., Chesnutt B.M., Yuan Y., Yang Y., Appleford M., Oh S., et al. The integration of chitosan-coated titanium in bone: an in vivo study in rabbits. Implant Dent 2007, 16:66-79.
112. Goldmann O., Rohde M., Chhatwal G.S., Medina E. Role of macrophages in host resistance to group A streptococci. Infect Immun 2004, 72:2956-2963.
113. Dipietro L.A., Reintjes M.G., Low Q.E., Levi B., Gamelli R.L. Modulation of macrophage recruitment into wounds by monocyte chemoattractant protein-1. Wound Repair Regen 2001, 9:28-33.
114. Fuentes M.E., Durham S.K., Swerdel M.R., Lewin A.C., Barton D.S., Megill J.R., et al. Controlled recruitment of monocytes and macrophages to specific organs through transgenic expression of monocyte chemoattractant protein-1. J Immunol 1995, 155:5769-5776.
115. Li B., Jiang B., Dietz M.J., Smith E.S., Clovis N.B., Rao K.M. Evaluation of local MCP-1 and IL-12 nanocoatings for infection prevention in open fractures. J Orthop Res 2010, 28:48-54.
116. Muszanska A.K., Busscher H.J., Herrmann A., van der Mei H.C., Norde W. Pluronic-lysozyme conjugates as anti-adhesive and antibacterial bifunctional polymers for surface coating. Biomaterials 2011, 32:6333-6341.
117. Smith R.S., Zhang Z., Bouchard M., Li J., Lapp H.S., Brotske G.R., et al. Vascular catheters with a nonleaching poly-sulfobetaine surface modification reduce thrombus formation and microbial attachment. Sci Transl Med 2012, 4:153ra32.
118. Brohede U., Forsgren J., Roos S., Mihranyan A., Engqvist H., Stromme M. Multifunctional implant coatings providing possibilities for fast antibiotics loading with subsequent slow release. J Mater Sci Mater Med 2009, 20:1859-1867.
119. Bruellhoff K., Fiedler J., Moller M., Groll J., Brenner R.E. Surface coating strategies to prevent biofilm formation on implant surfaces. Int J Artif Organs 2010, 33:646-653.